Tandem Therapeutics Alternatives & Competitors
12 companies similar to Tandem Therapeutics — Unlocking the matrix barrier to treat fibrotic diseases
Companies similar to Tandem Therapeutics
PRISM BioLab Co., Ltd.
PRISM BioLab is a biotechnology company with PepMetics Technology, a proprietary drug disc...
Japan
Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Allschwil, Switzerland
Senex Biotechnology. Inc.
Preventing Adaptive Drug Resistance and Cancer Metastasis
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
Amsterdam, The Netherland...
Rival Readout
Competing with Tandem Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Seattle, United States
Molecure
Fate can be altered.
Warsaw, Poland
Arvinas
Leading the way in targeted protein degradation therapeutics
New Haven, United States
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
Applied Immune Technologies
Pioneering innovative therapeutic solutions with specialized antibodies for cancer, viral,...
Tarveda Therapeutics
To discover, develop and commercialize a new class of potent and selective precision oncol...
Watertown, United States
Saverna Therapeutics AG
Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecule...
Allschwil, Switzerland
About Tandem Therapeutics
Tandem Therapeutics is a Swiss biopharmaceutical company on a mission to Unlocking the matrix barrier to treat fibrotic diseases. Leveraging over 15 years of research and development at ETH Zürich and Paul Scherrer Institut, the company focuses on pioneering precision targeting approaches to fibrosis and fibrotic cance...
Biopharmaceutical Company, Fibrotic Diseases, Precision Targeting, Fibrosis, Extracellular Matrix, Matrix Targeting Peptides, Therapeutic Platform, ETH Zürich, Paul Scherrer Institut, Organ Fibrosis, Cancer Treatment, Swiss, Discovery Stage, Transformative Research
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tandem Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tandem Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
